QUALYS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that QUALYS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $94.80M | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $93.07M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | $88.83M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $86.26M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $84.66M | Feb 22, 2021 |
| FY2020 | Sep 30, 2019 | $82.67M | Feb 22, 2021 |
| FY2020 | Jun 30, 2019 | $78.93M | Feb 22, 2021 |
| FY2020 | Mar 31, 2019 | $75.34M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $74.20M | Feb 21, 2020 |
| FY2019 | Sep 30, 2018 | $71.66M | Feb 21, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $669.13M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $607.57M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $554.46M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $489.72M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $411.17M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $362.96M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $321.61M | Feb 22, 2022 |
| FY2018 | Dec 31, 2018 | $74.20M | Feb 27, 2019 |
| FY2018 | Dec 31, 2017 | $62.92M | Feb 27, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $554.36M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $496.09M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $446.97M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $386.94M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $321.73M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $283.74M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $252.09M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $212.70M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $179.25M | Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $40.55M | Feb 24, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.32M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $173.68M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $151.60M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $107.99M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $70.96M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $23.82M | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $22.74M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | $26.32M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $18.69M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $20.66M | Feb 22, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $221.95M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $187.20M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $163.07M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $130.55M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $87.68M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $24.41M | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $26.30M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | $25.51M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $20.43M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $19.55M | Feb 22, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.28M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $111.85M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $110.47M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $101.19M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $81.29M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $72.55M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $68.24M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $53.26M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $42.82M | Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $8.89M | Feb 24, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309.40M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $244.09M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $244.61M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $198.85M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $200.62M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $180.09M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $160.61M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $125.46M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $107.65M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $69.31M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.99M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $12.33M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $8.79M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $15.36M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $24.42M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $30.04M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $27.57M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $22.78M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $37.82M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $23.25M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $973.54M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $812.62M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $700.94M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $814.56M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $736.82M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $675.61M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $585.68M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $537.53M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $407.00M | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $533.93M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $496.42M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $444.44M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $411.81M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $377.85M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $332.34M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $288.81M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $227.69M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $193.98M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $148.59M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $561.15M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $477.12M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $368.17M | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $289.13M | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $436.71M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $404.48M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $386.80M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $357.99M | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $343.54M | Feb 22, 2021 |
| FY2019 | Dec 31, 2016 | $258.41M | Feb 21, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.45M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $7.45M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $7.45M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $7.45M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $7.45M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.45M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $7.45M | Feb 22, 2021 |
| FY2020 | Dec 31, 2018 | $7.23M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $1.5K | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $317.0K | Feb 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($166.66M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($189.22M) | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | ($228.08M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | ($221.45M) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | ($41.66M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.57M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $23.19M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $27.96M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $39.92M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | ($8.26M) | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $250.26M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $232.18M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $203.67M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $173.72M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $137.33M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $74.13M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $87.56M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $41.03M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $86.59M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $86.74M | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35.73M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 36.50M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 36.91M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 37.36M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 39.11M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 39.25M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 39.15M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 38.60M | Feb 21, 2020 |
| FY2018 | Sep 30, 2018 | 39.02M | Feb 27, 2019 |
| FY2018 | Dec 31, 2017 | 38.60M | Feb 27, 2019 |